These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 18380953)

  • 1. Cardiovascular disease in women.
    Stevenson JC
    Menopause Int; 2008 Mar; 14(1):5. PubMed ID: 18380953
    [No Abstract]   [Full Text] [Related]  

  • 2. Menopause, hormone replacement therapy and hemorheology.
    Vayá A; Chorro P; Juliá D; Falcó C; Ortega L; Corella D; Aznar J
    Clin Hemorheol Microcirc; 2004; 30(3-4):277-81. PubMed ID: 15258354
    [No Abstract]   [Full Text] [Related]  

  • 3. [Using pausogest for hormone replacement therapy--effect on plasma lipoproteins in menopause women].
    Tsvetkov K; Monastirska M; Angelova M
    Akush Ginekol (Sofiia); 2008; 47 Suppl 1():29-32. PubMed ID: 18935856
    [No Abstract]   [Full Text] [Related]  

  • 4. What about breast cancer and cardiovascular disease risks with the best treatments during the climacterium and beyond.
    Neves-e-Castro M
    Gynecol Endocrinol; 2005 Jun; 20(6):301-4. PubMed ID: 16019377
    [No Abstract]   [Full Text] [Related]  

  • 5. Postmenopausal hormone therapy and the risk of cardiovascular disease.
    Stramba-Badiale M
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):303-9. PubMed ID: 19430340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Joint position statement of Polish Gynecologic Society, Polish Cardiological Society, and Polish Menopause and Andropause Society on the effect of hormone replacement therapy on cardiovascular system].
    Kornacewicz-Jach Z; Czarnecka D; Rynkiewicz A; Kotarski J; Paszkowski T; Pertyński T; Debski R; Wielgoś M
    Kardiol Pol; 2009 Jan; 67(1):72-6. PubMed ID: 19253195
    [No Abstract]   [Full Text] [Related]  

  • 7. Re-think HRT: behind the scene of perceptions.
    Pines A
    Climacteric; 2008; 11(6):443-6. PubMed ID: 18991073
    [No Abstract]   [Full Text] [Related]  

  • 8. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
    Rosano GM; Maffei S; Andreassi MG; Vitale C; Vassalle C; Gambacciani M; Stramba-Badiale M; Mercuro G
    J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):85-92. PubMed ID: 19145119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome and the menopause.
    Kaaja RJ
    Menopause Int; 2008 Mar; 14(1):21-5. PubMed ID: 18380957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes and the menopause.
    Wedisinghe L; Perera M
    Maturitas; 2009 Jul; 63(3):200-3. PubMed ID: 19535207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular health and the menopause - an approach for gynecologists: an overview.
    Mendelsohn M; Lobo R
    Climacteric; 2006 Sep; 9 Suppl 1():1-5. PubMed ID: 16899437
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hormone replacement therapy and cardiovascular risk in postmenopausal women].
    Kovacev-Zavisić B; Icin T; Kovacev N
    Med Pregl; 2009; 62 Suppl 3():85-90. PubMed ID: 19702123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of cardiovascular events in early menopause: a possible role for hormone replacement therapy.
    Antonicelli R; Olivieri F; Morichi V; Urbani E; Mais V
    Int J Cardiol; 2008 Nov; 130(2):140-6. PubMed ID: 18617278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The medical management of menopause: to treat or not to treat?
    Barlow DH
    Ann N Y Acad Sci; 2008 Apr; 1127():134-9. PubMed ID: 18443341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hormone replacement therapy and cardiovascular prevention. Where are we now?].
    Lerman J; Siseles N
    Medicina (B Aires); 2008; 68(3):251-7. PubMed ID: 18689159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oophorectomy and cardiovascular mortality: is there a link?
    Parker WH; Manson JE
    Menopause; 2009; 16(1):1-2. PubMed ID: 18971791
    [No Abstract]   [Full Text] [Related]  

  • 17. Risks of hormone therapy in the 50-59 year age group.
    van de Weijer PH
    Maturitas; 2008 May; 60(1):59-64. PubMed ID: 18556157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum urate, menopause, and postmenopausal hormone use: from eminence to evidence-based medicine.
    Gaffo AL; Saag KG
    Arthritis Res Ther; 2008; 10(5):120. PubMed ID: 18983690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Conventional hormonal replacement therapy in treatment of osteoporosis].
    Meczekalski B; Czyzyk A
    Pol Merkur Lekarski; 2009 Jul; 27(157):72-6. PubMed ID: 19650436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postmenopausal hormone therapy and the risk of cardiovascular disease.
    Bittner V
    Expert Opin Pharmacother; 2009 Sep; 10(13):2041-53. PubMed ID: 19563274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.